Investigators employed preclinical models of blast phase chronic myeloid leukemia to investigate the efficacy and underlying mechanism of leukemia stem cells-targeting with venetoclax/TKI combinations.
[Haematologica]
Home Newsletters Cancer Stem Cell News Lysosomal Acid Lipase a Modulates Leukemia Stem Cell Response to Venetoclax/Tyrosine Kinase...
